Related Experiment Video
Updated: Mar 12, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Docosahexaenoic Acid and Preterm Birth
1South Australian Health and Medical Research Institute (SAHMRI), Adelaide, S.A., Australia.
Insights
Omega-3 (n-3) long-chain polyunsaturated fatty acid (LCPUFA) supplementation during pregnancy may help delay birth. This review examines evidence on n-3 LCPUFA
Area of Science:
- Obstetrics and Gynecology
- Nutritional Science
- Perinatal Medicine
Background:
- Preterm birth is a leading cause of perinatal complications and infant mortality.
- Many preterm births have unknown causes, lacking effective prevention strategies.
- High fish consumption is linked to longer gestation periods.
Purpose of the Study:
- To review evidence on prenatal omega-3 (n-3) long-chain polyunsaturated fatty acid (LCPUFA) supplementation.
- To discuss the relationship between n-3 LCPUFA intake and preterm birth incidence.
- To evaluate n-3 LCPUFA as a potential prophylactic intervention.
Main Methods:
- Systematic review of randomized controlled trials.
- Analysis of epidemiological data on fish consumption and gestation length.
- Synthesis of current evidence on n-3 LCPUFA supplementation during pregnancy.
Main Results:
- Randomized controlled trials suggest n-3 LCPUFA supplementation may delay birth timing.
- Evidence indicates potential prophylactic value in certain populations.
- Further research is ongoing to confirm efficacy and optimal use.
Conclusions:
- Prenatal n-3 LCPUFA supplementation shows promise in potentially reducing preterm birth.
- Dietary n-3 LCPUFA may be a valuable intervention for some pregnant women.
- Understanding the role of n-3 LCPUFA in pregnancy is crucial for improving perinatal outcomes.
Abstract:
Preterm birth accounts for more than 85% of all perinatal complications and deaths. There are many short- and long-term consequences of being born too soon. These infants often require intensive care and are at increased risk of early morbidities often with life-long sequelae. Approximately 50% of all preterm births have unknown or unclear causes, and there are no effective primary prevention strategies in widespread clinical use. Epidemiological studies have observed an increased length of gestation in populations with high fish consumption. These findings have led to randomised controlled trials of omega-3 (n-3) long-chain polyunsaturated fatty acid (LCPUFA) supplementation which show that these dietary agents may delay the timing of birth and may have value as a prophylactic intervention in some women. This review presents the available evidence and discusses the relationship between prenatal n-3 LCPUFA supplementation during pregnancy and the incidence of preterm birth.
More Related Videos
03:19Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
